PDF(Pubmed)
Abstract：
To develop and update evidence-based and consensus-based guidelines on laparoscopic and robotic pancreatic surgery.
Minimally invasive pancreatic surgery (MIPS), including laparoscopic and robotic surgery, is complex and technically demanding. Minimizing the risk for patients requires stringent, evidence-based guidelines. Since the International Miami Guidelines on MIPS in 2019, new developments and key publications have been reported, necessitating an update.
Evidence-based guidelines on 22 topics in 8 domains were proposed: terminology, indications, patients, procedures, surgical techniques and instrumentation, assessment tools, implementation and training, and artificial intelligence. The Brescia Internationally Validated European Guidelines on Minimally Invasive Pancreatic Surgery (EGUMIPS, September 2022) used the Scottish Intercollegiate Guidelines Network (SIGN) methodology to assess the evidence and develop guideline recommendations, the Delphi method to establish consensus on the recommendations among the Expert Committee, and the AGREE II-GRS tool for guideline quality assessment and external validation by a Validation Committee.
Overall, 27 European experts, 6 international experts, 22 international Validation Committee members, 11 Jury Committee members, 18 Research Committee members, and 121 registered attendees of the 2-day meeting were involved in the development and validation of the guidelines. In total, 98 recommendations were developed, including 33 on laparoscopic, 34 on robotic, and 31 on general MIPS, covering 22 topics in 8 domains. Out of 98 recommendations, 97 reached at least 80% consensus among the experts and congress attendees, and all recommendations were externally validated by the Validation Committee.
The EGUMIPS evidence-based guidelines on laparoscopic and robotic MIPS can be applied in current clinical practice to provide guidance to patients, surgeons, policy-makers, and medical societies.
Minimally invasive pancreatic surgery (MIPS), including laparoscopic and robotic surgery, is complex and technically demanding. Minimizing the risk for patients requires stringent, evidence-based guidelines. Since the International Miami Guidelines on MIPS in 2019, new developments and key publications have been reported, necessitating an update.
Evidence-based guidelines on 22 topics in 8 domains were proposed: terminology, indications, patients, procedures, surgical techniques and instrumentation, assessment tools, implementation and training, and artificial intelligence. The Brescia Internationally Validated European Guidelines on Minimally Invasive Pancreatic Surgery (EGUMIPS, September 2022) used the Scottish Intercollegiate Guidelines Network (SIGN) methodology to assess the evidence and develop guideline recommendations, the Delphi method to establish consensus on the recommendations among the Expert Committee, and the AGREE II-GRS tool for guideline quality assessment and external validation by a Validation Committee.
Overall, 27 European experts, 6 international experts, 22 international Validation Committee members, 11 Jury Committee members, 18 Research Committee members, and 121 registered attendees of the 2-day meeting were involved in the development and validation of the guidelines. In total, 98 recommendations were developed, including 33 on laparoscopic, 34 on robotic, and 31 on general MIPS, covering 22 topics in 8 domains. Out of 98 recommendations, 97 reached at least 80% consensus among the experts and congress attendees, and all recommendations were externally validated by the Validation Committee.
The EGUMIPS evidence-based guidelines on laparoscopic and robotic MIPS can be applied in current clinical practice to provide guidance to patients, surgeons, policy-makers, and medical societies.
摘要：
目的：制定和更新基于证据和共识的腹腔镜和机器人胰腺手术指南。
背景：微创胰腺手术（MIPS），包括腹腔镜和机器人手术，是复杂和技术要求。最小化患者的风险需要严格的，循证指南。自2019年国际迈阿密MIPS指南以来，已经报道了新的发展和主要出版物，需要更新。
方法：针对8个领域的22个主题提出了基于证据的指南：术语，适应症,病人,程序,外科技术和器械，评估工具，实施和培训，和人工智能。布雷西亚国际公认的微创胰腺手术欧洲指南（EGUMIPS，2022年9月）使用苏格兰校际指南网络（SIGN）方法来评估证据并制定指南建议，德尔菲法在专家委员会之间就建议达成共识，用于方法学指南质量评估的AGREEII-GRS工具，以及由验证委员会进行的外部验证。
结果：总体而言，27位欧洲专家，6位国际专家,22名国际验证委员会成员，11名陪审团成员，18个研究委员会成员，在为期两天的会议中,121名注册与会者参与了指南的制定和验证.总的来说,提出了98项建议，包括33例腹腔镜手术，34个关于机器人，31个关于一般MIPS，涵盖8个领域的22个主题。在98项建议中，97在专家和大会与会者中达成了至少80％的共识，所有建议均由验证委员会外部验证。
结论：关于腹腔镜和机器人MIPS的EGUMIPS循证指南可应用于当前的临床实践，为患者提供指导，外科医生,政策制定者和医疗社会。
背景：微创胰腺手术（MIPS），包括腹腔镜和机器人手术，是复杂和技术要求。最小化患者的风险需要严格的，循证指南。自2019年国际迈阿密MIPS指南以来，已经报道了新的发展和主要出版物，需要更新。
方法：针对8个领域的22个主题提出了基于证据的指南：术语，适应症,病人,程序,外科技术和器械，评估工具，实施和培训，和人工智能。布雷西亚国际公认的微创胰腺手术欧洲指南（EGUMIPS，2022年9月）使用苏格兰校际指南网络（SIGN）方法来评估证据并制定指南建议，德尔菲法在专家委员会之间就建议达成共识，用于方法学指南质量评估的AGREEII-GRS工具，以及由验证委员会进行的外部验证。
结果：总体而言，27位欧洲专家，6位国际专家,22名国际验证委员会成员，11名陪审团成员，18个研究委员会成员，在为期两天的会议中,121名注册与会者参与了指南的制定和验证.总的来说,提出了98项建议，包括33例腹腔镜手术，34个关于机器人，31个关于一般MIPS，涵盖8个领域的22个主题。在98项建议中，97在专家和大会与会者中达成了至少80％的共识，所有建议均由验证委员会外部验证。
结论：关于腹腔镜和机器人MIPS的EGUMIPS循证指南可应用于当前的临床实践，为患者提供指导，外科医生,政策制定者和医疗社会。
